• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Targets for corona vaccine identified by scientists

|

New Delhi, June 09: Scientists have identified regions of the SARS-CoV-2 virus that causes COVID-19 to target with a vaccine, by harnessing tools used for the development of cancer immunotherapies.

The researchers at Children's Hospital of Philadelphia (CHOP) in the US employed the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the novel coronavirus.

Targets for corona vaccine identified by scientists

Using this strategy, the researchers believe a resulting vaccine would provide protection across the human population and drive a long-term immune response.

Covid-19 vaccine: Oxford to take volunteers from Brazil for clinical trials

"In many ways, cancer behaves like a virus, so our team decided to use the tools we developed to identify unique aspects of childhood cancers that can be targeted with immunotherapies and apply those same tools to identify the right protein sequences to target in SARS-CoV-2," said John M Maris, a pediatric oncologist at CHOP, and a professor at the University of Pennsylvania.

"We think our approach provides a roadmap for a vaccine that would be both safe and effective and could be produced at scale," said Maris, senior author of the research published in the journal Cell Reports Medicine.

The COVID-19 pandemic has led to an urgent need for the development of a safe and effective vaccine against SARS-CoV-2, the virus that causes the COVID-19 disease, the researchers said.

    Delhi Health Minister claims 50% have no contact, Centre says no community spread | Oneindia News

    An optimally designed vaccine maximises a long-lasting immune response, while minimising adverse reactions, autoimmunity, or disease exacerbation, they said.

    To increase the likelihood that a vaccine is both safe and effective, the research team prioritised parameters in identifying regions of the virus to target.

    The researchers looked for regions that would stimulate a memory T-cell response that, when paired with the right B cells, would drive memory B cell formation and provide lasting immunity and do so across the majority of human genomes.

    They targeted regions of SARS-CoV-2 that are present across multiple related coronaviruses, as well as new mutations that increase infectivity, while also ensuring that those regions were as dissimilar as possible from sequences naturally occurring in humans to maximise safety.

    CCMB paving way towards COVID-19 vaccine development

    The researchers propose a list of 65 peptide sequences that, when targeted, offer the greatest probability of providing population-scale immunity.

    The team will now test various combinations of a dozen or so of these sequences in mouse models to assess their safety and effectiveness.

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more